Cargando…
Downregulation of miR-101 contributes to epithelial-mesenchymal transition in cisplatin resistance of NSCLC cells by targeting ROCK2
Chemoresistance and epithelial-mesenchymal transition (EMT) in cancer are linked phenomena. EMT contributes to chemoresistance, however, little is known about whether chemotherapy can induce EMT in cancer cells. Here, we found that miR-101 expression was downregulated in cisplatin-resistant non-smal...
Autores principales: | Ye, Zhiqiang, Yin, Shengli, Su, Zhongzhen, Bai, Mingjun, Zhang, Haibo, Hei, Ziqing, Cai, Songwang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122329/ https://www.ncbi.nlm.nih.gov/pubmed/27229528 http://dx.doi.org/10.18632/oncotarget.6852 |
Ejemplares similares
-
LncRNA SNHG1 upregulates ROCK2 to reduce cisplatin sensitivity of NSCLC cells by targeting miR-101-3p
por: Wei, Lei, et al.
Publicado: (2019) -
Indie Rock 101
por: Turgeon, Richard
Publicado: (2012) -
Downregulation of DOCK1 sensitizes bladder cancer cells to cisplatin through preventing epithelial–mesenchymal transition
por: Chen, Da-jin, et al.
Publicado: (2016) -
Association of the Epithelial–Mesenchymal Transition (EMT) with Cisplatin Resistance
por: Ashrafizadeh, Milad, et al.
Publicado: (2020) -
Disabled-2 downregulation promotes epithelial-to-mesenchymal transition
por: Martin, J C, et al.
Publicado: (2010)